P.E.R. Spronk

709 total citations
17 papers, 481 citations indexed

About

P.E.R. Spronk is a scholar working on Cancer Research, Oncology and Surgery. According to data from OpenAlex, P.E.R. Spronk has authored 17 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 13 papers in Oncology and 10 papers in Surgery. Recurrent topics in P.E.R. Spronk's work include Breast Cancer Treatment Studies (14 papers), Global Cancer Incidence and Screening (9 papers) and Breast Implant and Reconstruction (8 papers). P.E.R. Spronk is often cited by papers focused on Breast Cancer Treatment Studies (14 papers), Global Cancer Incidence and Screening (9 papers) and Breast Implant and Reconstruction (8 papers). P.E.R. Spronk collaborates with scholars based in Netherlands, United States and France. P.E.R. Spronk's co-authors include Marie-Jeanne T. F. D. Vrancken Peeters, Carolien H. Smorenburg, José H. Volders, Sabine Siesling, Thijs van Dalen, Thilo Hackert, Jens Werner, Frank Bergmann, Markus W. Büchler and Ulf Hinz and has published in prestigious journals such as Annals of Surgery, Plastic & Reconstructive Surgery and Annals of Surgical Oncology.

In The Last Decade

P.E.R. Spronk

17 papers receiving 477 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
P.E.R. Spronk 277 261 257 139 78 17 481
A.C.M. van Bommel 277 1.0× 191 0.7× 198 0.8× 84 0.6× 37 0.5× 28 430
Carlie K. Thompson 219 0.8× 126 0.5× 245 1.0× 76 0.5× 67 0.9× 18 472
Carmen C. van der Pol 424 1.5× 240 0.9× 249 1.0× 311 2.2× 65 0.8× 37 648
Gustavo Calado de Aguiar Ribeiro 312 1.1× 176 0.7× 165 0.6× 172 1.2× 82 1.1× 16 495
Christopher Baliski 128 0.5× 241 0.9× 120 0.5× 58 0.4× 90 1.2× 21 427
Elvira L. Vos 220 0.8× 294 1.1× 135 0.5× 140 1.0× 165 2.1× 36 569
Wanda Szymanski 235 0.8× 184 0.7× 320 1.2× 190 1.4× 18 0.2× 9 531
Brooke Vuong 86 0.3× 237 0.9× 365 1.4× 69 0.5× 166 2.1× 38 555
Federico Frusone 112 0.4× 74 0.3× 158 0.6× 109 0.8× 47 0.6× 25 311
Luc J.E.E. Scheijmans 176 0.6× 69 0.3× 192 0.7× 106 0.8× 28 0.4× 10 323

Countries citing papers authored by P.E.R. Spronk

Since Specialization
Citations

This map shows the geographic impact of P.E.R. Spronk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.E.R. Spronk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.E.R. Spronk more than expected).

Fields of papers citing papers by P.E.R. Spronk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.E.R. Spronk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.E.R. Spronk. The network helps show where P.E.R. Spronk may publish in the future.

Co-authorship network of co-authors of P.E.R. Spronk

This figure shows the co-authorship network connecting the top 25 collaborators of P.E.R. Spronk. A scholar is included among the top collaborators of P.E.R. Spronk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.E.R. Spronk. P.E.R. Spronk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Spronk, P.E.R., et al.. (2022). Health care professionals overestimate the risk for locoregional recurrences after breast cancer treatment depending on their specialty. Breast Cancer Research and Treatment. 193(2). 293–303. 3 indexed citations
2.
Vos, Elvira L., Hester F. Lingsma, Agnes Jager, et al.. (2020). Effect of Case-Mix and Random Variation on Breast Cancer Care Quality Indicators and Their Rankability. Value in Health. 23(9). 1191–1199. 15 indexed citations
3.
Spronk, P.E.R., Husna Begum, Arul Earnest, et al.. (2020). Toward International Harmonization of Breast Implant Registries: International Collaboration of Breast Registry Activities Global Common Data Set. Plastic & Reconstructive Surgery. 146(2). 255–267. 23 indexed citations
4.
Boer, Mintsje de, P.E.R. Spronk, Annette H. Bruggink, et al.. (2019). The Dutch Breast Implant Registry: Registration of Breast Implant–Associated Anaplastic Large Cell Lymphoma—A Proof of Concept. Plastic & Reconstructive Surgery. 143(5). 1298–1306. 21 indexed citations
5.
Spronk, P.E.R., Marc A.M. Mureau, Sabine Siesling, et al.. (2019). Breast-Contour-Preserving Procedure as a Multidisciplinary Parameter of Esthetic Outcome in Breast Cancer Treatment in The Netherlands. Annals of Surgical Oncology. 26(6). 1704–1711. 11 indexed citations
6.
Spronk, P.E.R., Juliëtte Hommes, Xavier H.A. Keuter, et al.. (2019). How to improve patient safety and quality of care in breast implant surgery? First outcomes from the Dutch Breast Implant Registry (2015–2017). Journal of Plastic Reconstructive & Aesthetic Surgery. 72(10). 1607–1615. 18 indexed citations
7.
Schreuder, K., John H. Maduro, P.E.R. Spronk, et al.. (2018). Variation in the Use of Boost Irradiation in Breast-Conserving Therapy in the Netherlands: The Effect of a National Guideline and Cofounding Factors. Clinical Oncology. 31(4). 250–259. 12 indexed citations
8.
Spronk, P.E.R., Kelly M. de Ligt, A.C.M. van Bommel, et al.. (2018). Current decisions on neoadjuvant chemotherapy for early breast cancer: Experts’ experiences in the Netherlands. Patient Education and Counseling. 101(12). 2111–2115. 5 indexed citations
9.
Spronk, P.E.R., José H. Volders, Petrousjka van den Tol, Carolien H. Smorenburg, & Marie-Jeanne T. F. D. Vrancken Peeters. (2018). Breast conserving therapy after neoadjuvant chemotherapy; data from the Dutch Breast Cancer Audit. European Journal of Surgical Oncology. 45(2). 110–117. 44 indexed citations
10.
Schreuder, K., P.E.R. Spronk, JC Oosterwijk, et al.. (2018). Hospital transfer after a breast cancer diagnosis: A population-based study in the Netherlands of the extent, predictive characteristics and its impact on time to treatment. European Journal of Surgical Oncology. 45(4). 560–566. 7 indexed citations
11.
Volders, José H., Vera L. Negenborn, P.E.R. Spronk, et al.. (2017). Breast-conserving surgery following neoadjuvant therapy-a systematic review on surgical outcomes. Breast Cancer Research and Treatment. 168(1). 1–12. 58 indexed citations
12.
Ligt, Kelly M. de, P.E.R. Spronk, A.C.M. van Bommel, et al.. (2017). Patients' experiences with decisions on timing of chemotherapy for breast cancer. The Breast. 37. 99–106. 9 indexed citations
13.
Spronk, P.E.R., A.C.M. van Bommel, Sabine Siesling, et al.. (2017). Variation in use of neoadjuvant chemotherapy in patients with stage III breast cancer: Results of the Dutch national breast cancer audit. The Breast. 36. 34–38. 20 indexed citations
14.
Spronk, P.E.R., Guusje Vugts, Thijs van Dalen, et al.. (2017). Trends on Axillary Surgery in Nondistant Metastatic Breast Cancer Patients Treated Between 2011 and 2015. Annals of Surgery. 268(6). 1084–1090. 53 indexed citations
15.
Bommel, A.C.M. van, P.E.R. Spronk, Marie-Jeanne T. F. D. Vrancken Peeters, et al.. (2016). Clinical auditing as an instrument for quality improvement in breast cancer care in the Netherlands: The national NABON Breast Cancer Audit. Journal of Surgical Oncology. 115(3). 243–249. 68 indexed citations
16.
Spronk, P.E.R., Joost van Rosmalen, Marc H. W. A. Wijnen, et al.. (2014). Diagnosis and treatment of lymph node metastases in pediatric rhabdomyosarcoma in the Netherlands. Journal of Pediatric Surgery. 49(3). 416–419. 12 indexed citations
17.
Hartwig, Werner, Alexander Gluth, Ulf Hinz, et al.. (2014). Total Pancreatectomy for Primary Pancreatic Neoplasms. Annals of Surgery. 261(3). 537–546. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026